▶ 調査レポート

世界のマレック病ワクチン市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Marek's Disease Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のマレック病ワクチン市場 2021:企業別、地域別、種類・用途別 / Global Marek's Disease Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-111D11419資料のイメージです。• レポートコード:GIR-111D11419
• 出版社/出版日:GlobalInfoResearch / 2021年10月
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥393,240 (USD3,480)▷ お問い合わせ
  Multi User¥589,860 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、マレック病ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マレック病ワクチンの種類別市場規模(二価ワクチン、一価ワクチン)、用途別市場規模(獣医薬局、オンライン販売、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・マレック病ワクチンの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Merck、Ceva、Zoetis、Boehringer Ingelheim、Guangdong Wen's Dahuanong Biotechnology Co., Ltd.、Merial、Ruipu Biopharmaceutical Co., Ltd.、Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.、Beijing Huadu Shihua Biological Products Co., Ltd.、Guangxi Lichengdong Biological Co., Ltd.
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:二価ワクチン、一価ワクチン
・用途別分析2016年-2026年:獣医薬局、オンライン販売、その他
・マレック病ワクチンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・マレック病ワクチンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・マレック病ワクチンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・マレック病ワクチンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・マレック病ワクチンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Marek’s Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Marek’s Disease Vaccine size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Marek’s Disease Vaccine market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Marek’s Disease Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Bivalent Vaccine
Monovalent Vaccine

Market segment by Application can be divided into
Veterinary Pharmacy
Online Sale
Others

The key market players for global Marek’s Disease Vaccine market are listed below:
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen’s Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Marek’s Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Marek’s Disease Vaccine, with price, sales, revenue and global market share of Marek’s Disease Vaccine from 2019 to 2021.
Chapter 3, the Marek’s Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Marek’s Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Marek’s Disease Vaccine market forecast, by regions, type and distribution channel, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Marek’s Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Marek’s Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Marek’s Disease Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bivalent Vaccine
1.2.3 Monovalent Vaccine
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global Marek’s Disease Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Global Marek’s Disease Vaccine Market Size & Forecast
1.4.1 Global Marek’s Disease Vaccine Sales in Value (2016-2026))
1.4.2 Global Marek’s Disease Vaccine Sales in Volume (2016-2026)
1.4.3 Global Marek’s Disease Vaccine Price by Type (2016-2026) & (US$/Unit)
1.5 Global Marek’s Disease Vaccine Production Capacity Analysis
1.5.1 Global Marek’s Disease Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Marek’s Disease Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Marek’s Disease Vaccine Market Drivers
1.6.2 Marek’s Disease Vaccine Market Restraints
1.6.3 Marek’s Disease Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Marek’s Disease Vaccine Product and Services
2.1.4 Merck Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Ceva
2.2.1 Ceva Details
2.2.2 Ceva Major Business
2.2.3 Ceva Marek’s Disease Vaccine Product and Services
2.2.4 Ceva Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Marek’s Disease Vaccine Product and Services
2.3.4 Zoetis Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Marek’s Disease Vaccine Product and Services
2.4.4 Boehringer Ingelheim Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Guangdong Wen’s Dahuanong Biotechnology Co., Ltd.
2.5.1 Guangdong Wen’s Dahuanong Biotechnology Co., Ltd. Details
2.5.2 Guangdong Wen’s Dahuanong Biotechnology Co., Ltd. Major Business
2.5.3 Guangdong Wen’s Dahuanong Biotechnology Co., Ltd. Marek’s Disease Vaccine Product and Services
2.5.4 Guangdong Wen’s Dahuanong Biotechnology Co., Ltd. Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merial
2.6.1 Merial Details
2.6.2 Merial Major Business
2.6.3 Merial Marek’s Disease Vaccine Product and Services
2.6.4 Merial Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Ruipu Biopharmaceutical Co., Ltd.
2.7.1 Ruipu Biopharmaceutical Co., Ltd. Details
2.7.2 Ruipu Biopharmaceutical Co., Ltd. Major Business
2.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek’s Disease Vaccine Product and Services
2.7.4 Ruipu Biopharmaceutical Co., Ltd. Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
2.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Details
2.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
2.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek’s Disease Vaccine Product and Services
2.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Beijing Huadu Shihua Biological Products Co., Ltd.
2.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Details
2.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Major Business
2.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek’s Disease Vaccine Product and Services
2.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Guangxi Lichengdong Biological Co., Ltd.
2.10.1 Guangxi Lichengdong Biological Co., Ltd. Details
2.10.2 Guangxi Lichengdong Biological Co., Ltd. Major Business
2.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek’s Disease Vaccine Product and Services
2.10.4 Guangxi Lichengdong Biological Co., Ltd. Marek’s Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Marek’s Disease Vaccine Sales by Manufacturer
3.1 Global Marek’s Disease Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Marek’s Disease Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Marek’s Disease Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Marek’s Disease Vaccine Manufacturer Market Share
3.4.2 Top 6 Marek’s Disease Vaccine Manufacturer Market Share
3.5 Global Marek’s Disease Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Marek’s Disease Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Marek’s Disease Vaccine Market Size by Region
4.1.1 Global Marek’s Disease Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Marek’s Disease Vaccine Revenue by Region (2016-2026)
4.2 North America Marek’s Disease Vaccine Revenue (2016-2026)
4.3 Europe Marek’s Disease Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Marek’s Disease Vaccine Revenue (2016-2026)
4.5 South America Marek’s Disease Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Marek’s Disease Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Marek’s Disease Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Marek’s Disease Vaccine Revenue by Type (2016-2026)
5.3 Global Marek’s Disease Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Marek’s Disease Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Marek’s Disease Vaccine Revenue by Application (2016-2026)
6.3 Global Marek’s Disease Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Marek’s Disease Vaccine Sales by Type (2016-2026)
7.2 North America Marek’s Disease Vaccine Sales by Application (2016-2026)
7.3 North America Marek’s Disease Vaccine Market Size by Country
7.3.1 North America Marek’s Disease Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Marek’s Disease Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Marek’s Disease Vaccine Sales by Type (2016-2026)
8.2 Europe Marek’s Disease Vaccine Sales by Application (2016-2026)
8.3 Europe Marek’s Disease Vaccine Market Size by Country
8.3.1 Europe Marek’s Disease Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Marek’s Disease Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Marek’s Disease Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Marek’s Disease Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Marek’s Disease Vaccine Market Size by Region
9.3.1 Asia-Pacific Marek’s Disease Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Marek’s Disease Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Marek’s Disease Vaccine Sales by Type (2016-2026)
10.2 South America Marek’s Disease Vaccine Sales by Application (2016-2026)
10.3 South America Marek’s Disease Vaccine Market Size by Country
10.3.1 South America Marek’s Disease Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Marek’s Disease Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Marek’s Disease Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Marek’s Disease Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Marek’s Disease Vaccine Market Size by Country
11.3.1 Middle East & Africa Marek’s Disease Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Marek’s Disease Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Marek’s Disease Vaccine Typical Distributors
12.3 Marek’s Disease Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer